These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8573998)

  • 1. Characteristics of MHC antigen expression and tumor-infiltrating mononuclear cells in renal cell adenomas and carcinomas.
    Ohmori T; Okada K; Arita N; Watanabe Y; Miyazaki T; Tabei R
    Histol Histopathol; 1995 Oct; 10(4):789-94. PubMed ID: 8573998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reaction patterns of tumor infiltrating lymphocytes in different renal cell carcinomas and oncocytomas.
    Störkel S; Keymer R; Steinbach F; Thoenes W
    Prog Clin Biol Res; 1992; 378():217-23. PubMed ID: 1363795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
    Brasanac D; Marković-Lipkovski J; Hadzi-Djokić J; Müller GA; Müller CA
    Neoplasma; 1999; 46(3):173-8. PubMed ID: 10613593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma.
    Gastl G; Ebert T; Finstad CL; Sheinfeld J; Gomahr A; Aulitzky W; Bander NH
    J Urol; 1996 Jan; 155(1):361-7. PubMed ID: 7490887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of tumor-infiltrating antigen presenting cells by high intensity focused ultrasound ablation of human breast cancer.
    Xu ZL; Zhu XQ; Lu P; Zhou Q; Zhang J; Wu F
    Ultrasound Med Biol; 2009 Jan; 35(1):50-7. PubMed ID: 18950932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma.
    Ibrahim EC; Guerra N; Lacombe MJ; Angevin E; Chouaib S; Carosella ED; Caignard A; Paul P
    Cancer Res; 2001 Sep; 61(18):6838-45. PubMed ID: 11559559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA molecule expression in cutaneous squamous cell carcinomas: an immunopathological study and clinical-immunohistopathological correlations.
    García-Plata D; Mozos E; Carrasco L; Solana R
    Histol Histopathol; 1993 Apr; 8(2):219-26. PubMed ID: 7683937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomorphological characteristics of renal cell carcinoma.
    Markovic-Lipkovski J; Brasanac D; Todorovic V; Müller CA; Müller GA
    Histol Histopathol; 1995 Jul; 10(3):651-9. PubMed ID: 7579814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical correlates of response to recombinant interleukin-2-based immunotherapy in humans.
    Rubin JT; Elwood LJ; Rosenberg SA; Lotze MT
    Cancer Res; 1989 Dec; 49(24 Pt 1):7086-92. PubMed ID: 2582450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines.
    Mulders P; Tso CL; Gitlitz B; Kaboo R; Hinkel A; Frand S; Kiertscher S; Roth MD; deKernion J; Figlin R; Belldegrun A
    Clin Cancer Res; 1999 Feb; 5(2):445-54. PubMed ID: 10037196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.
    Bukur J; Rebmann V; Grosse-Wilde H; Luboldt H; Ruebben H; Drexler I; Sutter G; Huber C; Seliger B
    Cancer Res; 2003 Jul; 63(14):4107-11. PubMed ID: 12874014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA expression in basal cell carcinomas.
    Garcia-Plata D; Mozos E; Sierra MA; Peña J; Solana R
    Invasion Metastasis; 1991; 11(3):166-73. PubMed ID: 1834604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of histocompatibility antigens and characterization of mononuclear cell infiltrates in normal and neoplastic colorectal tissues of humans.
    Umpleby HC; Heinemann D; Symes MO; Williamson RC
    J Natl Cancer Inst; 1985 Jun; 74(6):1161-8. PubMed ID: 3158771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of HLA-DR is reduced in tumor infiltrating immune cells (TIICs) and regional lymph nodes of non-small-cell lung carcinomas. A putative mechanism of tumor-induced immunosuppression?
    Foukas PG; Tsilivakos V; Zacharatos P; Mariatos G; Moschos S; Syrianou A; Asimacopoulos PJ; Bramis J; Fotiadis C; Kittas C; Gorgoulis VG
    Anticancer Res; 2001; 21(4A):2609-15. PubMed ID: 11724329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA class I antigens expression in renal cell carcinoma: histopathological and clinical correlation.
    Brasanac D; Müller CA; Müller GA; Hadzi-Dzokic J; Markovic-Lipkovski J
    J Exp Clin Cancer Res; 1999 Dec; 18(4):505-10. PubMed ID: 10746977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation.
    Chaux P; Moutet M; Faivre J; Martin F; Martin M
    Lab Invest; 1996 May; 74(5):975-83. PubMed ID: 8642792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody to a proximal nephrogenic renal antigen: immunohistochemical analysis of formalin-fixed, paraffin-embedded human renal cell carcinomas.
    Yoshida SO; Imam A
    Cancer Res; 1989 Apr; 49(7):1802-9. PubMed ID: 2466563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of major histocompatibility complex antigens and adhesion molecules on renal cell carcinoma cells, and effect of interferon-alpha and/or cimetidine on the expression].
    Wu XX; Mizutani Y; Kakehi Y; Nakamura E; Mitsumori K; Takahashi T; Terachi T; Okada Y; Yoshida O
    Hinyokika Kiyo; 1998 Sep; 44(9):621-6. PubMed ID: 9805665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Turning tumor cells in situ into T-helper cell-stimulating, MHC class II tumor epitope-presenters: immuno-curing and immuno-consolidation.
    Hillman GG; Kallinteris NL; Lu X; Wang Y; Wright JL; Li Y; Wu S; Forman JD; Gulfo JV; Humphreys RE; Xu M
    Cancer Treat Rev; 2004 May; 30(3):281-90. PubMed ID: 15059651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.